0
     

Report Added
Report already added
Single Use Technologies for Biopharmaceuticals Market - Global Outlook and Forecast 2022-2028

Single Use Technologies for Biopharmaceuticals Market - Global Outlook and Forecast 2022-2028

This report contains market size and forecasts of Single Use Technologies for Biopharmaceuticals in Global, including the following market information:

Global Single Use Technologies for Biopharmaceuticals Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Single Use Technologies for Biopharmaceuticals market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Single-use Bioreactors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Single Use Technologies for Biopharmaceuticals include EMD Millipore, GE Healthcare, Pall Corp, Sartorius Stedim Biotech and Thermo Fisher, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Single Use Technologies for Biopharmaceuticals companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Single Use Technologies for Biopharmaceuticals Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Single Use Technologies for Biopharmaceuticals Market Segment Percentages, by Type, 2021 (%)
Single-use Bioreactors
Membrane Adsorbers
Media Bags
Bioprocess Containers
Others
Global Single Use Technologies for Biopharmaceuticals Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Single Use Technologies for Biopharmaceuticals Market Segment Percentages, by Application, 2021 (%)
Contract Manufacturing Organizations
Biopharmaceutical Manufacturers
Global Single Use Technologies for Biopharmaceuticals Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Single Use Technologies for Biopharmaceuticals Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Single Use Technologies for Biopharmaceuticals revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Single Use Technologies for Biopharmaceuticals revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
EMD Millipore
GE Healthcare
Pall Corp
Sartorius Stedim Biotech
Thermo Fisher
Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Single Use Technologies for Biopharmaceuticals Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Single Use Technologies for Biopharmaceuticals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Single Use Technologies for Biopharmaceuticals Overall Market Size
2.1 Global Single Use Technologies for Biopharmaceuticals Market Size: 2021 VS 2028
2.2 Global Single Use Technologies for Biopharmaceuticals Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Single Use Technologies for Biopharmaceuticals Players in Global Market
3.2 Top Global Single Use Technologies for Biopharmaceuticals Companies Ranked by Revenue
3.3 Global Single Use Technologies for Biopharmaceuticals Revenue by Companies
3.4 Top 3 and Top 5 Single Use Technologies for Biopharmaceuticals Companies in Global Market, by Revenue in 2021
3.5 Global Companies Single Use Technologies for Biopharmaceuticals Product Type
3.6 Tier 1, Tier 2 and Tier 3 Single Use Technologies for Biopharmaceuticals Players in Global Market
3.6.1 List of Global Tier 1 Single Use Technologies for Biopharmaceuticals Companies
3.6.2 List of Global Tier 2 and Tier 3 Single Use Technologies for Biopharmaceuticals Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Single Use Technologies for Biopharmaceuticals Market Size Markets, 2021 & 2028
4.1.2 Single-use Bioreactors
4.1.3 Membrane Adsorbers
4.1.4 Media Bags
4.1.5 Bioprocess Containers
4.1.6 Others
4.2 By Type - Global Single Use Technologies for Biopharmaceuticals Revenue & Forecasts
4.2.1 By Type - Global Single Use Technologies for Biopharmaceuticals Revenue, 2017-2022
4.2.2 By Type - Global Single Use Technologies for Biopharmaceuticals Revenue, 2023-2028
4.2.3 By Type - Global Single Use Technologies for Biopharmaceuticals Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Single Use Technologies for Biopharmaceuticals Market Size, 2021 & 2028
5.1.2 Contract Manufacturing Organizations
5.1.3 Biopharmaceutical Manufacturers
5.2 By Application - Global Single Use Technologies for Biopharmaceuticals Revenue & Forecasts
5.2.1 By Application - Global Single Use Technologies for Biopharmaceuticals Revenue, 2017-2022
5.2.2 By Application - Global Single Use Technologies for Biopharmaceuticals Revenue, 2023-2028
5.2.3 By Application - Global Single Use Technologies for Biopharmaceuticals Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Single Use Technologies for Biopharmaceuticals Market Size, 2021 & 2028
6.2 By Region - Global Single Use Technologies for Biopharmaceuticals Revenue & Forecasts
6.2.1 By Region - Global Single Use Technologies for Biopharmaceuticals Revenue, 2017-2022
6.2.2 By Region - Global Single Use Technologies for Biopharmaceuticals Revenue, 2023-2028
6.2.3 By Region - Global Single Use Technologies for Biopharmaceuticals Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Single Use Technologies for Biopharmaceuticals Revenue, 2017-2028
6.3.2 US Single Use Technologies for Biopharmaceuticals Market Size, 2017-2028
6.3.3 Canada Single Use Technologies for Biopharmaceuticals Market Size, 2017-2028
6.3.4 Mexico Single Use Technologies for Biopharmaceuticals Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Single Use Technologies for Biopharmaceuticals Revenue, 2017-2028
6.4.2 Germany Single Use Technologies for Biopharmaceuticals Market Size, 2017-2028
6.4.3 France Single Use Technologies for Biopharmaceuticals Market Size, 2017-2028
6.4.4 U.K. Single Use Technologies for Biopharmaceuticals Market Size, 2017-2028
6.4.5 Italy Single Use Technologies for Biopharmaceuticals Market Size, 2017-2028
6.4.6 Russia Single Use Technologies for Biopharmaceuticals Market Size, 2017-2028
6.4.7 Nordic Countries Single Use Technologies for Biopharmaceuticals Market Size, 2017-2028
6.4.8 Benelux Single Use Technologies for Biopharmaceuticals Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Single Use Technologies for Biopharmaceuticals Revenue, 2017-2028
6.5.2 China Single Use Technologies for Biopharmaceuticals Market Size, 2017-2028
6.5.3 Japan Single Use Technologies for Biopharmaceuticals Market Size, 2017-2028
6.5.4 South Korea Single Use Technologies for Biopharmaceuticals Market Size, 2017-2028
6.5.5 Southeast Asia Single Use Technologies for Biopharmaceuticals Market Size, 2017-2028
6.5.6 India Single Use Technologies for Biopharmaceuticals Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Single Use Technologies for Biopharmaceuticals Revenue, 2017-2028
6.6.2 Brazil Single Use Technologies for Biopharmaceuticals Market Size, 2017-2028
6.6.3 Argentina Single Use Technologies for Biopharmaceuticals Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Single Use Technologies for Biopharmaceuticals Revenue, 2017-2028
6.7.2 Turkey Single Use Technologies for Biopharmaceuticals Market Size, 2017-2028
6.7.3 Israel Single Use Technologies for Biopharmaceuticals Market Size, 2017-2028
6.7.4 Saudi Arabia Single Use Technologies for Biopharmaceuticals Market Size, 2017-2028
6.7.5 UAE Single Use Technologies for Biopharmaceuticals Market Size, 2017-2028
7 Players Profiles
7.1 EMD Millipore
7.1.1 EMD Millipore Corporate Summary
7.1.2 EMD Millipore Business Overview
7.1.3 EMD Millipore Single Use Technologies for Biopharmaceuticals Major Product Offerings
7.1.4 EMD Millipore Single Use Technologies for Biopharmaceuticals Revenue in Global Market (2017-2022)
7.1.5 EMD Millipore Key News
7.2 GE Healthcare
7.2.1 GE Healthcare Corporate Summary
7.2.2 GE Healthcare Business Overview
7.2.3 GE Healthcare Single Use Technologies for Biopharmaceuticals Major Product Offerings
7.2.4 GE Healthcare Single Use Technologies for Biopharmaceuticals Revenue in Global Market (2017-2022)
7.2.5 GE Healthcare Key News
7.3 Pall Corp
7.3.1 Pall Corp Corporate Summary
7.3.2 Pall Corp Business Overview
7.3.3 Pall Corp Single Use Technologies for Biopharmaceuticals Major Product Offerings
7.3.4 Pall Corp Single Use Technologies for Biopharmaceuticals Revenue in Global Market (2017-2022)
7.3.5 Pall Corp Key News
7.4 Sartorius Stedim Biotech
7.4.1 Sartorius Stedim Biotech Corporate Summary
7.4.2 Sartorius Stedim Biotech Business Overview
7.4.3 Sartorius Stedim Biotech Single Use Technologies for Biopharmaceuticals Major Product Offerings
7.4.4 Sartorius Stedim Biotech Single Use Technologies for Biopharmaceuticals Revenue in Global Market (2017-2022)
7.4.5 Sartorius Stedim Biotech Key News
7.5 Thermo Fisher
7.5.1 Thermo Fisher Corporate Summary
7.5.2 Thermo Fisher Business Overview
7.5.3 Thermo Fisher Single Use Technologies for Biopharmaceuticals Major Product Offerings
7.5.4 Thermo Fisher Single Use Technologies for Biopharmaceuticals Revenue in Global Market (2017-2022)
7.5.5 Thermo Fisher Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Single Use Technologies for Biopharmaceuticals Market Opportunities & Trends in Global Market
Table 2. Single Use Technologies for Biopharmaceuticals Market Drivers in Global Market
Table 3. Single Use Technologies for Biopharmaceuticals Market Restraints in Global Market
Table 4. Key Players of Single Use Technologies for Biopharmaceuticals in Global Market
Table 5. Top Single Use Technologies for Biopharmaceuticals Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Single Use Technologies for Biopharmaceuticals Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Single Use Technologies for Biopharmaceuticals Revenue Share by Companies, 2017-2022
Table 8. Global Companies Single Use Technologies for Biopharmaceuticals Product Type
Table 9. List of Global Tier 1 Single Use Technologies for Biopharmaceuticals Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Single Use Technologies for Biopharmaceuticals Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Single Use Technologies for Biopharmaceuticals Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Single Use Technologies for Biopharmaceuticals Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Single Use Technologies for Biopharmaceuticals Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Single Use Technologies for Biopharmaceuticals Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Single Use Technologies for Biopharmaceuticals Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Single Use Technologies for Biopharmaceuticals Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2023-2028
Table 30. EMD Millipore Corporate Summary
Table 31. EMD Millipore Single Use Technologies for Biopharmaceuticals Product Offerings
Table 32. EMD Millipore Single Use Technologies for Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 33. GE Healthcare Corporate Summary
Table 34. GE Healthcare Single Use Technologies for Biopharmaceuticals Product Offerings
Table 35. GE Healthcare Single Use Technologies for Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 36. Pall Corp Corporate Summary
Table 37. Pall Corp Single Use Technologies for Biopharmaceuticals Product Offerings
Table 38. Pall Corp Single Use Technologies for Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 39. Sartorius Stedim Biotech Corporate Summary
Table 40. Sartorius Stedim Biotech Single Use Technologies for Biopharmaceuticals Product Offerings
Table 41. Sartorius Stedim Biotech Single Use Technologies for Biopharmaceuticals Revenue (US$, Mn), (2017-2022)
Table 42. Thermo Fisher Corporate Summary
Table 43. Thermo Fisher Single Use Technologies for Biopharmaceuticals Product Offerings
Table 44. Thermo Fisher Single Use Technologies for Biopharmaceuticals Revenue (US$, Mn), (2017-2022)

List of Figures
Figure 1. Single Use Technologies for Biopharmaceuticals Segment by Type in 2021
Figure 2. Single Use Technologies for Biopharmaceuticals Segment by Application in 2021
Figure 3. Global Single Use Technologies for Biopharmaceuticals Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Single Use Technologies for Biopharmaceuticals Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Single Use Technologies for Biopharmaceuticals Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Single Use Technologies for Biopharmaceuticals Revenue in 2021
Figure 8. By Type - Global Single Use Technologies for Biopharmaceuticals Revenue Market Share, 2017-2028
Figure 9. By Application - Global Single Use Technologies for Biopharmaceuticals Revenue Market Share, 2017-2028
Figure 10. By Region - Global Single Use Technologies for Biopharmaceuticals Revenue Market Share, 2017-2028
Figure 11. By Country - North America Single Use Technologies for Biopharmaceuticals Revenue Market Share, 2017-2028
Figure 12. US Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Single Use Technologies for Biopharmaceuticals Revenue Market Share, 2017-2028
Figure 16. Germany Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 17. France Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Single Use Technologies for Biopharmaceuticals Revenue Market Share, 2017-2028
Figure 24. China Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 28. India Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Single Use Technologies for Biopharmaceuticals Revenue Market Share, 2017-2028
Figure 30. Brazil Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Single Use Technologies for Biopharmaceuticals Revenue Market Share, 2017-2028
Figure 33. Turkey Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Single Use Technologies for Biopharmaceuticals Revenue, (US$, Mn), 2017-2028
Figure 37. EMD Millipore Single Use Technologies for Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GE Healthcare Single Use Technologies for Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pall Corp Single Use Technologies for Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sartorius Stedim Biotech Single Use Technologies for Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Thermo Fisher Single Use Technologies for Biopharmaceuticals Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Report Title: Single Use Technologies for Biopharmaceuticals Market - Global Outlook and Forecast 2022-2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

US Bispecific Antibodies  Market & Clinical Pipeline Insight 2028

US Bispecific Antibodies Market & Clinical Pipeline Insight 2028

2023-2027 Vietnam Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Vietnam Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Venezuela Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Venezuela Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Uruguay Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Uruguay Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 United Arab Emirates Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 United Arab Emirates Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Ukraine Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Ukraine Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline